The dangers of the novel coronavirus seem to be bigger for those diagnosed with diabetes. According to the American Diabetes Association COVID-19 is, indeed, more complicated than the known flu, especially for diabetics. Proceeding with care is essential. The WHO (World Health Organization) warns people that those who are at risk of contracting the disease …

Understanding COVID-19 If You Have DiabetesRead More »

At least twenty years ago, researchers acknowledged that the action of PKCɛ (Protein Kinase C epsilon) causes diabetes. Based on their results, this liver enzyme impedes insulin activity on various insulin receptors. After this study, others followed, showing that cutting out the PKCɛ gene protected rodents from insulin resistance and glucose intolerance when they were …

The Surprising Role of Fat in DiabetesRead More »

Health Benefits of Apple and Medical Alert System Why rely on Apple for your health concerns? Well, innovation seems like a good enough reason to start. Not only does the popularity of the Apple company brand and its well-known reputation speak as a credential in itself, but at the same time, it’s important to understand …

Medical Alert SystemRead More »

Being a responsible eater during pregnancy determines the health of the developing fetus. Experts specializing in diabetes still do not know the exact cause of Type I diabetes. Yet studies show that eating a lot of gluten while pregnant promotes the development of this disease in infants. The study involved female Danish participants who agreed …

HIGHER RISK OF TYPE I DIABETES IN NEONATES IF MOMS EAT GLUTEN WHILE PREGNANTRead More »

CRISPR will pay ViaCyte to treat Type I Diabetes in the most unconventional way. ViaCyte will utilize the stem cells to create special pancreatic cells. They are not cells that are compatible with the patient’s individual cells. The introduction of these special cells might trigger a rejection attack from the immune system. This is where …

CRISPR GENE EDITING AND STEM CELLS FOR TYDIABETES TREATMENTS?Read More »